Search Results

ChemDiv announces a strategic collaboration with the University of Texas Medical Branch to facilitate the expansion of its inventory and advance the institution’s High-throughput Screening research programs.

Creative Enzymes, a leading biotechnology company specializing in enzyme research and development, is proud to announce the launch of its latest innovation, the Leaf-branch Compost Poly (ethylene terephthalate) Hydrolase.

Rigaku, a global solution partner in X-ray-analysis proudly announces the opening of its new Rigaku Taiwan Branch.

Looking for a job in Texas? Check out these nine companies hiring life sciences professionals like you.

In Texas, the Plano City Council approved a development agreement that supports a planned project that would bring over 3 million square feet of life sciences space to the area.

Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that as per a purchase order the Company received in late 2020, it has begun selling CompuFlo® disposables to the University of Texas Medical Branch at Galveston (UTMB), an institution of the University of Texas System and agency of the State of Texas. UTMB is a

Dr. Richard Matner, President of PlantPharm BioMed, Ltd. will be presenting at the International Symposium on One Health Research: Improving Food Security and Resilience, in Galveston, Texas April 21–23, 2024.

Milestone Scientific Inc. today reported it has commenced commercial sales of CompuFlo® disposables for use in neurostimulation spinal cord stimulator implantation procedures at the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital.

Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center became the first in the nation to use a novel pulsed field ablation (PFA) system to treat patients with paroxysmal and persistent atrial fibrillation, a heart arrhythmia that affects millions of people worldwide, after receiving approval by the U.S. Food and Drug Administration.